Should We Be Treating Affective Symptoms, Like Anxiety and Depression Which May Be Related to LUTD in Patients With OAB? ICI‐RS 2024
Open Access
- 16 January 2025
- journal article
- research article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 44 (3) , 661-667
Abstract
Aims: To discuss the role of screening and treatment of affective symptoms, like anxiety and depression in patients with LUTD. A review of the literature regarding the bidirectional association and multidisciplinary approaches integrating psychometric assessments with personalized treatment plans to improve diagnostic accuracy and therapeutic outcomes of LUTD.Methods: This review summarizes discussions and a narrative review of (recent) literature during an International Consultation on Incontinence‐Research Society 2024 research proposal with respect to the role of screening for anxiety and depression, effect of mental health symptoms on treatment outcomes and future implications.Results: Consensus recognized the importance to incorporate attention to anxiety and depression in relation to LUTD. The awareness of this association can lead to better outcomes. Future research projects are proposed to evaluate the bidirectional relationship.Conclusion: The relationship between affective symptoms and LUTD underscores the need for integrated treatment approaches that address both psychological and urological dimensions. Further research is required to identify specific patient subgroups that would benefit most from these interventions, to develop standardized screening tools, and to refine treatment protocols. Multidisciplinary care, incorporating psychological assessment and personalized treatment strategies, could enhance outcomes for LUTD patients.Keywords
This publication has 36 references indexed in Scilit:
- The association between pre‐diagnostic levels of psychological distress and adverse effects after radical prostatectomyBJUI Compass, 2024
- Change in depression predicts change in bladder symptoms for women with urinary incontinence undergoing pelvic-floor muscle trainingEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2022
- Who benefits from an eHealth‐based stress management intervention in advanced prostate cancer? Results from a randomized controlled trialPsycho-Oncology, 2022
- Systematic review exploring the relationship between sexual abuse and lower urinary tract symptomsInternational Urogynecology Journal, 2022
- Multidisciplinary treatment for functional urological disorders with psychosomatic comorbidity in a tertiary pelvic care center—A retrospective cohort studyNeurourology and Urodynamics, 2022
- Should we routinely assess psychological morbidities in idiopathic lower urinary tract dysfunction: ICI‐RS 2019?Neurourology and Urodynamics, 2020
- The urinary microbiome and its contribution to lower urinary tract symptoms; ICI‐RS 2015Neurourology and Urodynamics, 2017
- Prevalence of anxiety and depressive symptoms and their association with pelvic floor dysfunctions-A cross sectional cohort study at a Pelvic Care CentreNeurourology and Urodynamics, 2017
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trialEuropean Neuropsychopharmacology, 2004